Physician profile
Meg M Hainer
NPI 1942389028
$4,939.55
in general payments reported to CMS, 2019-2025
36 companies · $766 in 2025
The $766 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $569 · 2020: $311 · 2021: $661 · 2022: $955 · 2023: $1,067 · 2024: $610 · 2025: $766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,168 · Education: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,168.47 |
| Education | $273.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $812.85 | 2019-2025 | |
| Astellas Pharma US INC | $575.08 | 2023-2025 | Veozah |
| Evofem Biosciences, INC. | $485.56 | 2021-2025 | Phexxi, Solosec, Phexx |
| Pfizer INC. | $403.08 | 2019-2025 | |
| Exeltis, USA INC. | $379.69 | 2019-2025 | Slynd |
| Millicent US INC | $290.04 | 2019-2025 | Femring, Intrarosa, Femlyv |
| Agile Therapeutics, INC. | $241.43 | 2021-2024 | Twirla |
| Mayne Pharma Commercial LLC | $199.41 | 2021-2025 | |
| Avion Pharmaceuticals | $181.83 | 2019-2022 | |
| Myovant Sciences INC. | $152.16 | 2021-2022 | |
| Roche Diagnostics Corporation | $140.89 | 2019-2021 | |
| Lupin INC. | $127.70 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $118.74 | 2022 | |
| Therapeuticsmd, INC. | $98.85 | 2019-2022 | |
| Organon LLC | $91.59 | 2023-2024 | Nexplanon |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $82.84 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $68.76 | 2023-2025 | Myfembree, Gemtesa |
| Ascend Therapeutics US, LLC | $55.50 | 2020-2022 | |
| Exact Sciences Corporation | $44.21 | 2025 | Cologuard Collection Kit |
| Amgen INC. | $43.83 | 2021 | |
| Hologic Sales and Service, LLC | $34.25 | 2021-2022 | |
| Novo Nordisk INC | $32.73 | 2022-2025 | Wegovy |
| Lilly USA, LLC | $31.65 | 2022-2025 | Zepbound |
| Channel Medsystems, INC. | $29.43 | 2025 | |
| Mylan Pharmaceuticals INC. | $27.27 | 2020-2021 | |
| Coopersurgical, INC. | $25.98 | 2019-2022 | |
| Dysis Medical, INC. | $23.63 | 2020 | |
| Boston Scientific Corporation | $20.19 | 2023 | Varithena Administration Pack |
| Bayer Healthcare Pharmaceuticals INC. | $17.45 | 2025 | |
| Shield Therapeutics INC | $17.14 | 2025 | |
| Mycovia Pharmaceuticals, INC. | $15.63 | 2023 | Vivjoa |
| Sage Therapeutics, LLC | $15.49 | 2024 | |
| Biohaven Pharmaceuticals, INC. | $14.95 | 2021 | |
| Amag Pharmaceuticals, INC. | $14.00 | 2019 | |
| Celularity INC. | $14.00 | 2019 | |
| Minerva Surgical, INC | $11.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meg Hainer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.